Federated Hermes, Inc. Adaptive Biotechnologies Corp Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Federated Hermes, Inc. holds 11,259 shares of ADPT stock, worth $63,951. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,259

Previous 57,272 80.34%

Holding current value

$63,951

Previous $207,000 72.46%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$3.37 - $5.12 $155,063 - $235,586	-46,013 Reduced 80.34%	11,259 $57,000
Q2 2024 Aug 08, 2024	SELL	$2.34 - $3.96 $2.91 Million - $4.93 Million	-1,244,445 Reduced 95.6%	57,272 $207,000
Q1 2024 May 14, 2024	BUY	$2.88 - $4.8 $256,484 - $427,473	89,057 Added 7.34%	1,301,717 $4.18 Million
Q4 2023 Jan 31, 2024	SELL	$3.46 - $5.33 $597,012 - $919,675	-172,547 Reduced 12.46%	1,212,660 $5.94 Million
Q3 2023 Nov 13, 2023	BUY	$5.07 - $8.44 $1.38 Million - $2.3 Million	272,720 Added 24.51%	1,385,207 $7.55 Million
Q2 2023 Aug 14, 2023	SELL	$6.19 - $8.78 $393,492 - $558,135	-63,569 Reduced 5.41%	1,112,487 $7.46 Million
Q1 2023 May 08, 2023	SELL	$7.8 - $10.11 $1.8 Million - $2.34 Million	-231,130 Reduced 16.42%	1,176,056 $10.4 Million
Q4 2022 Feb 13, 2023	BUY	$6.26 - $9.34 $36,602 - $54,610	5,847 Added 0.42%	1,407,186 $10.8 Million
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $24,739 - $48,222	3,806 Added 0.27%	1,401,339 $9.98 Million
Q2 2022 Aug 15, 2022	BUY	$6.4 - $14.73 $5.38 Million - $12.4 Million	841,334 Added 151.26%	1,397,533 $11.3 Million
Q1 2022 May 13, 2022	BUY	$10.12 - $28.9 $5.63 Million - $16.1 Million	556,199 New	556,199 $7.72 Million
Q2 2021 Aug 16, 2021	SELL	$32.22 - $44.59 $1.35 Million - $1.87 Million	-42,000 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$37.26 - $67.74 $673,958 - $1.23 Million	-18,088 Reduced 30.1%	42,000 $1.69 Million
Q4 2020 Feb 12, 2021	BUY	$45.01 - $65.47 $814,140 - $1.18 Million	18,088 Added 43.07%	60,088 $3.55 Million
Q2 2020 Aug 13, 2020	SELL	$24.95 - $48.38 $356,685 - $691,640	-14,296 Reduced 25.39%	42,000 $2.03 Million
Q1 2020 May 13, 2020	BUY	$16.96 - $34.16 $153,674 - $309,523	9,061 Added 19.18%	56,296 $1.56 Million
Q4 2019 Feb 14, 2020	BUY	$24.56 - $32.8 $128,571 - $171,707	5,235 Added 12.46%	47,235 $1.41 Million
Q3 2019 Nov 14, 2019	SELL	$30.31 - $53.51 $1 Million - $1.77 Million	-33,000 Reduced 44.0%	42,000 $1.3 Million
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $3.02 Million - $3.62 Million	75,000 New	75,000 $3.62 Million

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $812M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Adaptive Biotechnologies Corp Transaction History